Leslie J Blackhall1,2, Paul Read3, George Stukenborg4, Patrick Dillon5, Joshua Barclay2, Andrew Romano5, James Harrison3. 1. 1 Department of Palliative Care, University of Virginia , Charlottesville, Virginia. 2. 2 Department of Internal Medicine, University of Virginia , Charlottesville, Virginia. 3. 3 Department of Public Health Sciences, University of Virginia , Charlottesville, Virginia. 4. 4 Department of Health Services Research, University of Virginia , Charlottesville, Virginia. 5. 5 Department of Medical Oncology, University of Virginia , Charlottesville, Virginia.
Abstract
BACKGROUND: Studies suggest that outpatient palliative care can reduce hospitalization and increase hospice utilization for patients with cancer, however there are insufficient resources to provide palliative care to all patients from time of diagnosis. It is also unclear whether inpatient consultation alone provides similar benefits. A better understanding of the timing, setting, and impact of palliative care for patients with cancer is needed. OBJECTIVES: The purpose of this study was to measure timing of referral to outpatient palliative care and impact on end-of-life (EOL) care. DESIGN: The Comprehensive Assessment with Rapid Evaluation and Treatment (CARE Track) program is a phased intervention integrating outpatient palliative care into cancer care. In Year 1 patients were referred at the discretion of their oncologist. SETTING: Academic medical center. MEASUREMENTS: We compared EOL hospitalization, hospice utilization, and costs of care for CARE Track patients compared to those never seen by palliative care or seen only in hospital. RESULTS: Patients were referred a median of 72.5 days prior to death. CARE Track patients had few hospitalizations at end of life, were less likely to die in hospital, had increased hospice utilization, and decreased costs of care; these results were significant even after controlling for differences between groups. Inpatient consultation alone did not impact these variables. However, only approximately half of patients with incurable cancers were referred to this program. CONCLUSION: Referral outpatient palliative care within 3 months of death improved EOL care and reduced costs, benefits not seen with inpatient care only. However, many patients were never referred, and methods of systematically identifying appropriate patients are needed.
BACKGROUND: Studies suggest that outpatient palliative care can reduce hospitalization and increase hospice utilization for patients with cancer, however there are insufficient resources to provide palliative care to all patients from time of diagnosis. It is also unclear whether inpatient consultation alone provides similar benefits. A better understanding of the timing, setting, and impact of palliative care for patients with cancer is needed. OBJECTIVES: The purpose of this study was to measure timing of referral to outpatient palliative care and impact on end-of-life (EOL) care. DESIGN: The Comprehensive Assessment with Rapid Evaluation and Treatment (CARE Track) program is a phased intervention integrating outpatient palliative care into cancer care. In Year 1 patients were referred at the discretion of their oncologist. SETTING: Academic medical center. MEASUREMENTS: We compared EOL hospitalization, hospice utilization, and costs of care for CARE Track patients compared to those never seen by palliative care or seen only in hospital. RESULTS:Patients were referred a median of 72.5 days prior to death. CARE Track patients had few hospitalizations at end of life, were less likely to die in hospital, had increased hospice utilization, and decreased costs of care; these results were significant even after controlling for differences between groups. Inpatient consultation alone did not impact these variables. However, only approximately half of patients with incurable cancers were referred to this program. CONCLUSION: Referral outpatient palliative care within 3 months of death improved EOL care and reduced costs, benefits not seen with inpatient care only. However, many patients were never referred, and methods of systematically identifying appropriate patients are needed.
Authors: Joan D Penrod; Partha Deb; Carol Luhrs; Cornelia Dellenbaugh; Carolyn W Zhu; Tsivia Hochman; Matthew L Maciejewski; Evelyn Granieri; R Sean Morrison Journal: J Palliat Med Date: 2006-08 Impact factor: 2.947
Authors: J Cameron Muir; Farrah Daly; Malene S Davis; Richard Weinberg; Jessica S Heintz; Thomas A Paivanas; Roy Beveridge Journal: J Pain Symptom Manage Date: 2010-07 Impact factor: 3.612
Authors: Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Frances C Brokaw; Janette Seville; Jay G Hull; Zhongze Li; Tor D Tosteson; Ira R Byock; Tim A Ahles Journal: JAMA Date: 2009-08-19 Impact factor: 56.272
Authors: Jennifer S Temel; Jessica McCannon; Joseph A Greer; Vicki A Jackson; Patricia Ostler; William F Pirl; Thomas J Lynch; J Andrew Billings Journal: Cancer Date: 2008-08-15 Impact factor: 6.860
Authors: Matthew Follwell; Debika Burman; Lisa W Le; Kristina Wakimoto; Dori Seccareccia; John Bryson; Gary Rodin; Camilla Zimmermann Journal: J Clin Oncol Date: 2008-12-08 Impact factor: 44.544
Authors: Richard Brumley; Susan Enguidanos; Paula Jamison; Rae Seitz; Nora Morgenstern; Sherry Saito; Jan McIlwane; Kristine Hillary; Jorge Gonzalez Journal: J Am Geriatr Soc Date: 2007-07 Impact factor: 5.562
Authors: Anjali V Desai; Virginia M Klimek; Kimberly Chow; Andrew S Epstein; Camila Bernal; Kelly Anderson; Molly Okpako; Robin Rawlins-Duell; Dana Kramer; Danielle Romano; Jessica I Goldberg; Judith E Nelson Journal: J Oncol Pract Date: 2018-12 Impact factor: 3.840
Authors: Kathleen Oare Lindell; Dio Kavalieratos; Kevin F Gibson; Laura Tycon; Margaret Rosenzweig Journal: Heart Lung Date: 2016-11-18 Impact factor: 2.210
Authors: Sandhya Yadav; Isaac W Heller; Nancy Schaefer; Ramzi G Salloum; Sheri M Kittelson; Diana J Wilkie; Jinhai Huo Journal: Support Care Cancer Date: 2020-05-21 Impact factor: 3.603
Authors: Joan G Carpenter; Meghan McDarby; Dawn Smith; Megan Johnson; Joshua Thorpe; Mary Ersek Journal: J Palliat Med Date: 2017-05-04 Impact factor: 2.947
Authors: Andrew M Romano; Kristine E Gade; Gradon Nielsen; Robert Havard; James H Harrison; Josh Barclay; George J Stukenborg; Paul W Read; Leslie J Blackhall; Patrick M Dillon Journal: Oncologist Date: 2017-02-20
Authors: Mali K Schneiter; Mohana B Karlekar; Marta A Crispens; Lauren S Prescott; Alaina J Brown Journal: Support Care Cancer Date: 2018-09-12 Impact factor: 3.603